---  
layout: startup_page  
title: "General Proximity"  
id: "generalproximity.bio"  
permalink: "/generalproximitygeneralproximity.bio01032025/"  
website: "https://www.generalproximity.bio/"  
funding_round: "Seed"  
funding_amount: "$16M"  
investors: "Aydin Senkut at Felicis, Y Combinator, Jim Dahl (Rock Creek), age1, Modi Ventures, Wilson Sonsini"  
about: "General Proximity is a biotechnology platform company pioneering the next generation of induced proximity medicines. Its OmniTAC platform enables precise modification of disease-driving proteins, opening therapeutic opportunities for previously undruggable targets. The company focuses on treatments for cancer, cardiometabolic disease, neurodegeneration, and longevity."  
markets: "Biotechnology, Oncology, Cardiometabolic Disease, Neurodegenerative Diseases, Longevity, Medical"  
hq: "San Francisco, California, United States"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/generalproximity"  
twitter: "https://twitter.com/proxbio"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/general-proximity-650b"  
pitchbook: "https://pitchbook.com/profiles/company/439898-59"  

date_display: "03-Jan-2025"  
date: "2025-01-03"

# SEO Optimization  
meta_title: "General Proximity - Seed Funding ($16M)"  
meta_description: "General Proximity, General Proximity is a biotechnology platform company pioneering the next generation of induced proximity medicines. Its OmniTAC platform enables prec..."  
meta_keywords: "General Proximity, Biotechnology, Oncology, Cardiometabolic Disease, Neurodegenerative Diseases, Longevity, Medical, Seed funding"  
canonical_url: "https://startup.projectstartups.com/generalproximitygeneralproximity.bio01032025/"  
---